999
Views
156
CrossRef citations to date
0
Altmetric
Original Article

Mini ReviewHuman Interferons Alpha, Beta and Omega

, , , &
Pages 243-251 | Published online: 07 Aug 2009

References

  • Brierley, M.M. and Fish, E. (2002) "IFN-a/b receptor interactions to biologic outcomes: understanding the circuitry", J. Interferon Cytokine Res. 22, 835–845.
  • Cutrone, E.C. and Langer, J.A. (1997) "Contributions of cloned Type I interferon receptor subunits to differential ligand binding", FEBS Lett. 404, 197–202.
  • David, M. (2002) "Signal transduction by Type I interferons", Biotechniques 33, S58-S65.
  • Deonarain, R., Chan, D.C.M., Platanias, L.C. and Fish, E.N. (2002) "Interferon-alpha/beta receptor interactions: a complex story unfolding", Curr. Pharma. Des. 8, 2131–2137.
  • Fasler-Kan, E., Pansky, A., Wiederkehr, M., Battegay, M. and Heim, M.H. (1998) "Interferon-activates signal transducers and activators of transcription 5 and 6 in Daudi cells", Eur. J. Biol. 3, 514–519.
  • Fitzgerald, K., Rowe, D.C. Barnes, B.J. Caffrey, D.R. Visintin, A., Latz, E., Monks, B., Pitha, P.M. and Golenbock, D.T. (2003) "LPS-TLR4 signaling to IRF3/7 and NF-KB involves the Toll Adapter TRAM and TRIF", J. Exp. Med. 198, 1043–1055.
  • Foster, G.R. and Finter, N.B. (1998) "Are all Type I interferons equivalent?", J. Viral Hepat. 5, 143–152.
  • Goodbourn, S., Didcock, L. and Randall, R.E. (2000) "Interferon's: cell signaling, immune modulation, antiviral responses and virus countermeasures", J. Gen. Virol. 81, 2341–2364.
  • Hu, R., Gan, Y., Liu, J., Miller, D. and Zoon, K.C. (1993) "Evidence for multiple binding sites for several components of human lympho-blastoid interferon-a", J. Biol. Chem. 268, 12591–12525.
  • Hu, R., Bekisz, J., Schmeisser, H., McPhie, P. and Zoon, K. (2001) "Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity", J. Immun. 167, 1482–1489.
  • Isaacs, A. and Lindenmann, J. (1957) "Virus interference: the interferon", Proc. R. Soc. Med. 147, 258–267.
  • Kalvakolanu, D.V. (2003) "Alternate interferon signaling pathways", Pharmacol. Ther. 100, 1–29.
  • Karpusas, M., Nolte, M., Benton, C.B. Meier, W., Lipscomb, W.N. and Goelz, S. (1997) "The crystal structure of human interferon b at 2.2 A resolution", Proc. Natl Acad. Sci. USA 94, 11813–11818.
  • Katze, M.G. He, Y. and Gale, M., Jr. (2002) "Viruses and interferon: a fight for supremacy", Nat. Rev./Immunol. 2, 675–687.
  • Klaus, W., Gsell, B., Labhardt, A.M. Wipf, B. and Senn, H. (1997) "The three-dimensional high resolution structure of human interferon alpha 2a determined by heteronuclear NMR spectroscopy in solution", J. Mol. Biol. 274, 661–675.
  • Korn, A.P. Rose, D.R. and Fish, E.N. (1994) "Three dimensional model of a human interferon-a consensus sequence", J Interferon Res. 14, 1–9.
  • Lefevre, F., Guillomot, M., D'Andrea, S., Battegay, S. and La Bonnardiere, C. (1998) "Interferon-delta: the first member of a novel Type I interferon family", Biochemie 80, 779–788.
  • Lekmine, F., Sassano, A., Uddin, S., Majchrzak, B., Miura, O., Druker, B.J. Fish, E.N. Imamoto, A. and Platanias, L.C. (2002) "The CrkL adapter protein is required for Type I Interferon-dependent gene transcription and activation of the small G-Protein Rap1", Biochem. Biophys. Res. Commun. 291, 744–750.
  • Lewerenz, M., Mogensen, K.E. and Uze, G. (1998) "Shared receptor components but distinct complexs for a and Interferon's", J. Mol. Biol. 282, 585–599.
  • Li, Y., Sassano, A., Majchrzak, B., Deb, D.K. Levy, D.E. Gaestel, M., Nebreda, A.R. Fish, E.N. and Platanias, L.C. (2004) "Role of p38a map kinase in Type I Interferon signaling", J. Biol. Chem. 279, 970–979.
  • Lim, J.K. Xiong, J., Carrasco, N. and Langer, J.A. (1994) "Intrinsic ligand binding properties of human and bovine alpha interferon receptor", FEBS Lett. 350, 281–286.
  • Ling, L.E. Zafari, M., Reardon, D., Brickelmaier, M., Goelz, S.E. and Benjamin, C.D. (1995) "Human Type I interferon receptor, IFNAR, is aheavily glycosylated 120-130 kDa membrane protein", J. Interferon Cytokine Res. 15, 55–56.
  • Lu, J., Chuntharapai, A., Beck, J., Bass, S., Ow, A., De Vos, A.M. Gibbs, V. and Kim, K.J. (1998) "Structure-function study of the extracellular domain of the human IFN-a receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2", J. Immunol. 160, 1782–1788.
  • Martal, J.L. Chene, N.M. Huynh, L.P. L'Haridon, R.M. Reinaud, P.B. Guillomot, M.W. Charlier, M.A. and Charpigny, S.Y. (1998) "IFN-tau: a novel subtype IIFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities", Biochemie 80, 755–777.
  • Novick, D., Cohen, B. and Rubinstein, M. (1994) "The human interferon a/b receptor: characterization and molecular cloning", Cell 77, 391–400.
  • Pfeffer, L.M. Basu, L., Pfeffer, S.R. Yang, C.H. Murti, A., Russell-Harde, D. and Croze, E. (1997) "The short form of the interferon a/p receptor chain 2 acts as a dominant negative for Type I interferon action", J. Biol. Chem. 272, 11002–11005.
  • Physicians' Desk Reference (2004) Medical Economics Company.
  • Piehler, J., Roisman, L.C. and Schreiber, G. (2000) "New structural and functional aspects of the Type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface", J. Biol. Chem. 275, 40425–40433.
  • Platanias, L.C. (2003) "The p38 mitogen-activated protein kinase pathway and its role in interferon signaling", Pharm. Ther. 98, 129–142.
  • Platanias, L.C. and Fish, E.N. (1999) "Signaling pathways activated by interferons", Exp. Hem. 27, 1583–1592.
  • Platanias, L.S. Uddin, P., Domanski, P. and Colamonici, O.R. (1996) "Differences in a and b signaling. Interferon beta selectively induces the interaction of the a and bL subunits of the Type I interferon receptor", J. Biol. Chem. 271, 23630–23633.
  • Radhakrishnan, R., Walter, L.J. Hruza, A., Reichert, P., Trotta, P.P. Nagabhushan, T.L. and Walter, M.R. (1996) "Zinc mediated dimer of human interferon-a2b revealed by X-ray crystallography", Structure 4, 1453–1463.
  • Russell-Harde, D., Pu, H., Betts, M., Harkins, R.N. Perez, H.D. and Croze, E. (1995) "Reconstitution of a high affinity binding site for Type I interferons", J. Biol. Chem. 270, 26033–26036.
  • Sen, G.C. (2001) "Viruses and interferons", Annu. Rev. Microbiol. 55, 255–281.
  • Seto, M.H. Harkins, R.N. Adler, M., Whitlow, M., Church, W.B. and Croze, E. (1995) "Homology model of human interferon-a8 and its receptor complex", Protein Sci. 4, 655–670.
  • Stark, G.R. Kerr, I.M. Williams, B.R. Silverman, R.H. and Schreiber, R.D. (1998) "How cells respond to interferons", Annu. Rev. Biochem. 67, 227–264.
  • Taniguchi, T. and Takaoka, A. (2002) "The interferon-a/b system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors", Curr. Opin. Immunol. 14, 111–116.
  • Uze, G., Lutfalla, G., Bandu, M.-T., Proudhon, D. and Mogensen, K.E. (1992) "Behaviour of a cloned murine interferon a/b receptor expressed in homospecific or heterospecific background", Proc. Natl Acad. Sci. USA 89, 4774–4778.
  • Uze, G., Lutfalla, G. and Mogensen, K.E. (1995) "a and b interferons and their receptors and their friends and relations", J. Interferon Cytokine Res. 15, 3–26.
  • Wang, K., Scheel-Toellner, D., Wong, S.H. Craddock, R., Caamano, J., Akbar, A.N. Salmon, M. and Lord, J.M. (2003) "Inhibition of neutrophil apoptosis by Type 1 IFN depends on cross-talk between phosphoinositol 3-Kinase protein kinase C-8, and NF-KB signaling pathways", J. Immunol. 171, 1035–1041.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.